Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Citi
Daiichi Sankyo
Cantor Fitzgerald
Chinese Patent Office
Express Scripts
Colorcon
Federal Trade Commission
QuintilesIMS
Harvard Business School

Generated: October 22, 2017

DrugPatentWatch Database Preview

KERLONE Drug Profile

« Back to Dashboard

What is the patent landscape for Kerlone, and what generic Kerlone alternatives are available?

Kerlone is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in KERLONE is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.

Summary for Tradename: KERLONE

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list97
Clinical Trials: see list1
Patent Applications: see list1,241
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KERLONE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
KERLONE
betaxolol hydrochloride
TABLET;ORAL019507-001Oct 27, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
KERLONE
betaxolol hydrochloride
TABLET;ORAL019507-002Oct 27, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Baxter
Merck
Teva
Cantor Fitzgerald
Daiichi Sankyo
Harvard Business School
Citi
US Army
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot